The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118650132 11865013 2 F 20160912 20151223 20160915 PER US-PFIZER INC-2015410060 PFIZER 75.00 YR F Y 0.00000 20160915 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118650132 11865013 1 PS HYDROMORPHONE HYDROCHLORIDE. HYDROMORPHONE HYDROCHLORIDE 1 UNK U 74598
118650132 11865013 2 SS MORPHINE SULFATE. MORPHINE SULFATE 1 UNK U 19999
118650132 11865013 3 C TYLENOL ACETAMINOPHEN 1 Oral 500 MG, AS NEEDED (500 MG, EVERY 6 HOURS, FREQ: AS NEEDED) 0 500 MG TABLET
118650132 11865013 4 C NORVASC AMLODIPINE BESYLATE 1 Oral 10 MG, DAILY 0 10 MG TABLET
118650132 11865013 5 C CARAFATE SUCRALFATE 1 Oral 1 G, 4X/DAY 0 1 G TABLET QID
118650132 11865013 6 C VITAMIN D CHOLECALCIFEROL 1 Oral UNK, DAILY 0
118650132 11865013 7 C COQ 10 UBIDECARENONE 1 Oral UNK, DAILY 0
118650132 11865013 8 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 1 DF, 1X/DAY (EVERY MORNING BEFORE BREAKFAST) 0 1 DF CAPSULE QD
118650132 11865013 9 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 40 MG, UNK (PATIENT TAKING DIFFERENTLY, FREQ: 2 DAY; INTERVAL: 1) 0 40 MG CAPSULE
118650132 11865013 10 C FLAXSEED FLAX SEED 1 Oral UNK, DAILY 0
118650132 11865013 11 C NORCO ACETAMINOPHENHYDROCODONE BITARTRATE 1 Oral 1 DF, AS NEEDED (EVERY 6 HOURS, FREQ: AS NEEDED) 0 1 DF TABLET
118650132 11865013 12 C FEMARA LETROZOLE 1 Oral 1 DF, DAILY 0 1 DF TABLET
118650132 11865013 13 C EMLA LIDOCAINEPRILOCAINE 1 UNK (APPLY TO MEDI PORT SITE 30 MINUTES PRIOR TO ACCESS) 0 CREAM
118650132 11865013 14 C HYZAAR HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM 1 Oral 1 DF, DAILY 0 1 DF TABLET
118650132 11865013 15 C IBRANCE PALBOCICLIB 1 Oral 1 DF, DAILY (DAILY WITH BREAKFAST THREE OUT OF EVERY FOUR WEEKS) 0 1 DF
118650132 11865013 16 C ZOLOFT SERTRALINE HYDROCHLORIDE 1 Oral 1 DF, 1X/DAY 0 1 DF TABLET QD
118650132 11865013 17 C PROBIOTIC PROBIOTICS NOS 1 Oral UNK, 2X/DAY 0 BID
118650132 11865013 18 C MULTIVITAMIN + MINERAL 2 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118650132 11865013 3 Pain
118650132 11865013 11 Pain

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
118650132 11865013 Nausea
118650132 11865013 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found